相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Voriconazole plasma levels in children are highly variable
I. Spriet et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Therapeutic Drug Monitoring of Voriconazole After Intravenous Administration in Infants and Children With Primary Immunodeficiency
Magdalena Gerin et al.
THERAPEUTIC DRUG MONITORING (2011)
Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
Thomas J. Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Michael Neely et al.
CLINICAL INFECTIOUS DISEASES (2010)
In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3
Souzan B. Yanni et al.
DRUG METABOLISM AND DISPOSITION (2010)
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)
Robert M. Ward et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
Koki Ueda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Hallucinations during voriconazole therapy
Dimitrios I. Zonios et al.
CLINICAL INFECTIOUS DISEASES (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases
Ana Burgos et al.
PEDIATRICS (2008)
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin
Roberto P. Santos et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight
K. Frankenbusch et al.
JOURNAL OF PERINATOLOGY (2006)
Pharmacokinetic/pharmacodynamic profile of voriconazole
Ursula Theuretzbacher et al.
CLINICAL PHARMACOKINETICS (2006)
Intravenous voriconazole therapy in a preterm infant
KM Muldrew et al.
PHARMACOTHERAPY (2005)
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Voriconazole: A new triazole antifungal agent
LB Johnson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection
HD Maples et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
TJ Walsh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
